Scientist to Watch

» evolution, behavior and cancer

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Yoav Gilad: Gene Regulator

Yoav Gilad: Gene Regulator

By | October 1, 2013

Professor, Department of Human Genetics, University of Chicago. Age: 38

3 Comments

image: Megan Carey: Cerebellum Prober

Megan Carey: Cerebellum Prober

By | August 1, 2012

Group Leader, Neuroscience Program, Champalimaud Center for the Unknown, Lisbon, Portugal; HHMI International Early Career Scientist; Age: 38

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

image: Corina Tarnita: The Ant Mathematician

Corina Tarnita: The Ant Mathematician

By | September 1, 2011

Junior Fellow, Harvard Society of Fellows, Harvard University. Age: 28

0 Comments

image: Seirian Sumner: Wasp Whisperer

Seirian Sumner: Wasp Whisperer

By | August 1, 2011

Research Fellow, Institute of Zoology, London. Age: 37

0 Comments

image: Harmit Malik: Viral Historian

Harmit Malik: Viral Historian

By | July 1, 2011

Member, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Age: 38

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech